Methods Mol Biol:斑马鱼眼外肌再生模型中的自噬作用综述

2018-11-24 MedSci MedSci原创

美国密歇根大学凯洛格眼科中心眼科学与视觉科学系的Saera-Vila A等研究人员,近日在Methods Mol Biol杂志上发表了一篇重要的综述论文。作者对手术肌肉损伤模型进行了详细的描述,对其用来研究自噬等实验方案也进行了讨论。

美国密歇根大学凯洛格眼科中心眼科学与视觉科学系的Saera-Vila A等研究人员,近日在Methods Mol Biol杂志上发表了一篇重要的综述论文。作者对手术肌肉损伤模型进行了详细的描述,对其用来研究自噬等实验方案也进行了讨论。

斑马鱼的眼外肌在严重损伤后可以进行再生。受损的肌细胞去分化成为间充质祖细胞状态,并重新进入细胞周期进行增殖、迁移和再分化成功能性肌肉细胞。去除分化过程是从肌节中多核合胞体肌纤维开始的,经过蛋白质机器的显着重塑和细胞器内容物的显着变化,最终以增殖的单核成肌细胞结束。

事实证明,在这个过程的早期,自噬起着关键作用,它可以降解肌节,也可以降解多核合胞体中多余的细胞核。由于斑马鱼重编程过程的稳健性及其相对的同步性,它可以作为研究自噬生物学的重要体内模型。

在这篇论文中,作者对手术肌肉损伤模型进行了详细的描述,对其用来研究自噬等实验方案也进行了讨论。本文为眼科研究者提供了系统的指导,也促进了眼科疾病的研究进展。

原文出处:

Saera-Vila, A., P.E. Kish, and A. Kahana, Autophagy in Zebrafish Extraocular Muscle Regeneration. Methods Mol Biol, 2019. 1854: p. 105-117.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
    2019-08-07 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
    2018-12-15 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
    2018-11-26 lg.zhao
  6. [GetPortalCommentsPageByObjectIdResponse(id=1896426, encodeId=6939189642617, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 07 03:58:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918417, encodeId=56a1191841ede, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Dec 15 15:58:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701078, encodeId=a72e1e01078b3, content=<a href='/topic/show?id=7a3fe274489' target=_blank style='color:#2F92EE;'>#眼外肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72744, encryptionId=7a3fe274489, topicName=眼外肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=904b30322649, createdName=119337467, createdTime=Thu Jan 31 02:58:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767570, encodeId=74a21e675709d, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 13 21:58:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420892, encodeId=beee14208921f, content=<a href='/topic/show?id=f4e85e9565c' target=_blank style='color:#2F92EE;'>#斑马鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57956, encryptionId=f4e85e9565c, topicName=斑马鱼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84283623605, createdName=lg.zhao, createdTime=Mon Nov 26 14:58:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047642, encodeId=4a3c104e64212, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Nov 25 02:58:00 CST 2018, time=2018-11-25, status=1, ipAttribution=)]
    2018-11-25 CHANGE

    梅斯里提供了很多疾病的模型计算公式,赞一个!

    0

相关资讯

J Neuroophthalmol. :病例报告-重症肌无力患者的眼外肌研究揭示潜在眼肌麻痹症治疗方法!

南非开普敦大学神经内科研究组的Rautenbach RM近日在最新的一期J Neuroophthalmol. 杂志上发表了一篇病例报告,他们首次指出:经过对眼麻痹症3.5年的临床治疗,对患有血清阴性重症肌无力(MG)患者的眼外肌(EOM)进行了组织病理学和超微结构组织分析。

先天性广泛眼外肌纤维化综合征伴下睑内翻倒睫1例

患儿女性,3岁。家长发现患儿右眼睁不大伴畏光、流泪3年;